Browse Related Topics For:

Amgen

266
Biosimilars
224
BPCIA
171
Pharmaceutical Patents
155
FDA
153
Patent Infringement
145
Patent Litigation
144
Patents
132
Pharmaceutical Industry
127
Sandoz v Amgen
120
Sandoz
108
Patent Dance
71
Commercial Marketing
70
Apotex
62
SCOTUS
60
Biologics
56
Notice Requirements
54
Preliminary Injunctions
53
FDA Approval
40
aBLA
39
Hospira
39
Popular
31
Appeals
27
Declaratory Judgments
23
AbbVie
23
Generic Drugs
21
Class Action
21
Prescription Drugs
17
Amgen Inc. v Connecticut Retirement Plans
17
Class Certification
17
Petition for Writ of Certiorari
15
ERISA
14
Biologics Price Competition and Innovation Act of 2009
14
Genentech
14
Securities Fraud
13
Fraud-on-the-Market
13
Inter Partes Review (IPR) Proceeding
13
Motion to Dismiss
12
Dismissals
12
Fiduciary Duty
12
Stock Drop Litigation
11
Certiorari
11
FIfth Third Bancorp v Dudenhoeffer
10
IP License
10
Life Sciences
10
Pfizer
9
Discovery
8
ANDA
8
Mylan Pharmaceuticals
8
Pleading Standards
8
State Law Claims
7
Allergan Inc
7
Coherus
7
Declaratory Relief
7
Employee Benefits
7
Hatch-Waxman
7
Healthcare
7
Injunctive Relief
7
Patent Applications
7
Patent Invalidity
7
Securities Litigation
7
Solicitor General
7
Unfair Competition
6
EU
6
Janssen Pharmaceuticals
6
Patent Trial and Appeal Board
6
Preemption
6
Rebuttable Presumptions
5
Biotechnology
5
Corporate Counsel
5
Damages
5
Disclosure Requirements
5
Duty of Prudence
5
Injunctions
5
Motion To Stay
5
Obviousness
5
Public Health Service Act
5
Subject Matter Jurisdiction
5
Teva Pharmaceuticals
4
Actavis Inc.
4
Affordable Care Act
4
All Writs Act
4
AstraZeneca
4
Breach of Duty
4
Citizen Petitions
4
Counterclaims
4
European Medicines Agency (EMA)
4
Halliburton
4
Oral Argument
4
Patent-Eligible Subject Matter
4
Remedies
4
Retirement Plan
3
401k
3
Advisory Committee
3
Amgen v Hospira
3
Canada
3
Celltrion
3
Claim Construction
3
Clinical Trials
3
Conversion
3
Declaratory Rulings
3
Disclosure
3
Dispute Resolution
3
Eli Lilly
3
En Banc Review
3
ESOP
3
Exclusive Remedy
3
Failure To State A Claim
3
Federal Rules of Civil Procedure
3
Information Sharing
3
Jurisdiction
3
License Applications
3
Licensing Rules
3
Marketing Authorization Application
3
Merck
3
Mootness
3
Motion for Summary Judgment
3
Motion to Compel
3
Permanent Injunctions
3
Petition For Rehearing
3
Safe Harbors
3
Samsung
3
SEC
3
Securities
3
Summary Judgment
2
American Express v Italian Colors Restaurant
2
Amgen v Sandoz
2
Amicus Briefs
2
Arbitration
2
Basic v Levinson
2
Boehringer
2
CAFA
2
CAFC
2
Class Action Arbitration Waivers
2
Collateral Order Doctrine
2
Discovery Disputes
2
Drug Approvals
2
Enablement Inquiries
2
Exclusivity
2
First Impression
2
Fraud
2
FRCP 26
2
Gabelli v SEC
2
GlaxoSmithKline
2
Halliburton v Erica P. John Fund
2
Inside Information
2
Intellectual Property Litigation
2
Intellectual Property Protection
2
Johnson & Johnson
2
Judicial Review
2
Loss Causation
2
Mandamus Petitions
2
Material Misstatements
2
Medicaid
2
Medicare
2
Motion for Judgment
2
On-Sale Bar
2
Orange Book
2
Oxford Health v Sutter
2
Patent Exhaustion
2
Patent Expiration
2
Patented Medicines
2
Pre-Market Notification
2
Private Right of Action
2
Public Meetings
2
Regeneron
2
Research and Development
2
Reverse Payment Settlement Agreements
2
Sanofi
2
Sanofi-Aventis
2
Securities Exchange Act
2
Standard Fire Ins. Co. v. Knowles
2
Stark Law
2
Statute of Limitations
2
Stipulations
2
UK
2
USPTO
2
Vacated
2
Wal-Mart
2
Writ of Mandamus
1
35 U.S.C. § 271(e)(1)
1
Accounting
1
Administrative Procedure Act
1
Affirmative Action
1
Affirmative Defenses
1
Alien Tort Statute
1
Allergan v Sandoz
1
Already LLC
1
Amended Regulation
1
America Invents Act
1
American Express
1
Amgen v Apotex
1
Amgen v Harris
1
AMP v Myriad
1
Anti-Kickback Statute
1
Appellate Jurisdiction
1
Article III
1
Assignments
1
Attorney-Client Privilege
1
Bayer
1
Biogen Idec
1
biologic
1
Books & Records
1
Bowman v Monsanto
1
BPCI
1
Breach of Contract
1
Bristol-Myers Squibb
1
Business Torts
1
Calculation of Damages
1
Cancer
1
Canning v NLRB
1
Certifications
1
CETA
1
CFTC
1
CGMP
1
Chadbourne & Parke LLP v Troice
1
Citizen Suits
1
Civil Conspiracy
1
Civil Monetary Penalty
1
Clinical Laboratory Testing
1
CMS
1
Comcast
1
Comcast v. Behrend
1
Comment Period
1
Community Trademark
1
Conflict Mineral Rules
1
Content Marketing
1
Contract Interpretation
1
Copyright
1
Corporate Governance
1
Covenant of Good Faith and Fair Dealing
1
Cross Motions
1
DaimlerChrysler
1
Declaratory Judgment Act
1
Defense Strategies
1
Defined Benefit Plans
1
Derivative Suit
1
Discovery Rule
1
DNA
1
Double Patent
1
Draft Guidance
1
Drug Pricing
1
Dukes v Wal-Mart
1
ESRD
1
Exhaustion Doctrine
1
Expert Testimony
1
Extrapolation
1
Extraterritoriality Rules
1
False Claims Act (FCA)
1
FDCA
1
Federal Arbitration Act
1
Federal Rule 12(b)(6)
1
FEHA
1
Filing Fees
1
Final Judgment
1
First Sale Doctrine
1
Fisher v University of Texas
1
FRCP 11
1
Free Trade Agreements
1
Fresenius
1
Frivolous Lawsuits
1
FTC v Actavis
1
Genetically Engineered Seed
1
Health Canada
1
Health Insurance
1
HHS
1
Hoffman LaRoche
1
Hollingsworth v Perry
1
Hospitals
1
Human Genes
1
Impression Products v Lexmark International
1
Indemnity Insurance
1
Infringement
1
Innovator Liability
1
Insider Trading
1
Inventions
1
Irreparable Harm
1
IRS
1
iTraxx CDS indices
1
Joint Venture
1
Judgment As A Matter Of Law
1
Kickbacks
1
Kirtsaeng v. John Wiley & Sons
1
Kyle Bass
1
Labeling
1
Legislative Agendas
1
License Agreements
1
Litigation Privilege
1
M&G Polymers v Tackett
1
Mandatory Victim's Restitution Act
1
Manufacturers
1
Marketing
1
Marketing Exclusivity Periods
1
Markman Hearing
1
Material Nonpublic Information
1
Materiality
1
Medical Devices
1
Medical Expenses
1
Medicare Access and CHIP Reauthorization (MACRA)
1
Method Claims
1
Misappropriation
1
Misrepresentation
1
Moench Presumption
1
Momenta
1
Montanile v Board of Trustees
1
More Harm Than Good Standard
1
Morgan Stanley
1
Motion to Expedite
1
Motion To Strike
1
Motion to Transfer
1
Mount Holly v Mt. Holly Citizens in Action
1
New Legislation
1
Nike
1
NLRB
1
No-Action Letters
1
Noninfringement
1
Notice and Comment
1
Notice of Appeal
1
Notice of Intent
1
Notice Provisions
1
Order To Compel
1
Partnerships
1
Patent Portfolios
1
Patent-in-Suit
1
Pay-For-Delay
1
Pensions
1
Personal Jurisdiction
1
Pharmacies
1
Physicians
1
Plan Administrators
1
Plan Participants
1
Pleadings
1
PMNOC Regulations
1
Preponderance of the Evidence
1
Principal Place of Business
1
Prior Art
1
Product Exclusivity
1
Public Use
1
Purple Book
1
Qualified Settlement Funds
1
Quarterly Report
1
Qui Tam
1
Reasonable Reliance Claims
1
Relators
1
Remand
1
Renewal Fees
1
Retaliation
1
Reversal
1
Ripeness
1
Rule 10b-5
1
Rule 23(b)(3)
1
Rule 23(f)
1
Rule 26
1
Rulemaking Process
1
Same-Sex Marriage
1
Scheduling Orders
1
Scienter
1
Scope of Discovery Requests
1
Sealed Records
1
Section 220 Request
1
Section 337
1
Section 8
1
Section 8(a)
1
Sham Litigation Exception
1
Shareholder Litigation
1
Sherman Act
1
SLUSA
1
Standing
1
Statutory Interpretation
1
Supervisors
1
Supremacy Clause
1
Supreme Court of Canada
1
TC Heartland LLC v Kraft Foods
1
Trade Secrets
1
Trademark Registration
1
Trials
1
TRICARE
1
TRO
1
UBS
1
UK Patents Act
1
Unclean Hands
1
Uniform Commercial Code (UCC)
1
US v Windsor
1
UT Southwestern Medical v Nassar
1
Utility Patents
1
Vance v. Ball State University
1
Venue
1
Whistleblowers
1
Whole Woman's Health v Hellerstedt
1
Willful Infringement
1
Work Product Privilege
1
Written Notice
1
Yard Man
1
Zika